Durable Efficacy Of Zenocutuzumab, A Her2 X Her3 Bispecific Antibody, In Advanced Nrg1 Fusion-Positive (Nrg1+) Non-Small Cell Lung Cancer (Nsclc)
Zenocutuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Durable Efficacy Of Zenocutuzumab, A Her2 X Her3 Bispecific Antibody, In Advanced Nrg1 Fusion-Positive (Nrg1+) Non-Small Cell Lung Cancer (Nsclc) ### Output: Zenocutuzumab